Status:

RECRUITING

A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy

Lead Sponsor:

Kazuya Hosokawa

Conditions:

Eisenmenger Syndrome

Pulmonary Arterial Hypertension of Congenital Heart Disease

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

What is this study about? This study will test whether adding sotatercept to usual medicines for pulmonary arterial hypertension (PAH) can help adults who have PAH due to unrepaired congenital heart d...

Eligibility Criteria

Inclusion Criteria:

  • adults (≥18 years)
  • unrepaired ASD, VSD or PDA
  • ≥90 days of pulmonary vasodilator therapy; and either (i) pulmonary vascular resistance (PVR) ≥5 Wood units and mean pulmonary arterial pressure (mPAP) > 20 mm Hg on right heart catheterization within 180 days, or (ii) echocardiographic tricuspid regurgitation velocity >3.4 m/s with right-to-left/bidirectional shunt plus resting SpO₂ ≤92% consistent with cyanosis
  • baseline 6MWD ≥100 m
  • ability to complete questionnaires

Exclusion Criteria:

  • WHO functional class IV; other unrepaired intracardiac shunts
  • severe renal/hepatic/parenchymal lung disease or LVEF <40%
  • prior sotatercept use
  • contraindication to sotatercept per label
  • investigator-judged unsuitability

Key Trial Info

Start Date :

October 7 2025

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

April 30 2028

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT07356778

Start Date

October 7 2025

End Date

April 30 2028

Last Update

January 21 2026

Active Locations (10)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 3 (10 locations)

1

Kyushu University Hospital

Fukuoka, Not Required For This Country, Japan, 8150014

2

The Second Department of Internal Medicine, University of Occupational and Environmental Health

Fukuoka, Japan

3

Division of Cardiovascular Medicine, Kobe University Hospital

Kobe, Japan

4

Department of Cardiovascular Medicine, Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Kyoto, Japan

A Study of Sotatercept for Patients With Eisenmenger Syndrome or Unrepaired Shunt-Associated Pulmonary Arterial Hypertension Resistant to Vasodilator Therapy | DecenTrialz